---
title: Near-death Experience in ICU Survivors
nct_id: NCT04279171
overall_status: COMPLETED
sponsor: University of Liege
study_type: OBSERVATIONAL
primary_condition: Critical Illness
countries: Belgium
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04279171.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04279171"
ct_last_update_post_date: 2022-04-05
last_seen_at: "2026-05-12T06:34:43.684Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Near-death Experience in ICU Survivors

**Official Title:** Incidence of Near-death Experiences Among Patients Who Survived a Critical Illness

**NCT ID:** [NCT04279171](https://clinicaltrials.gov/study/NCT04279171)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 126
- **Lead Sponsor:** University of Liege
- **Conditions:** Critical Illness, Near-Death Experience
- **Start Date:** 2019-06-01
- **Completion Date:** 2021-06-30
- **CT.gov Last Update:** 2022-04-05

## Brief Summary

This observational study aims to describe the incidence of near-death experience (NDE) in patients who survived a critical illness. In order to help determine the potential risk factors of NDE, dissociative status and spirituality are also investigated. Finally, in patients who experienced NDE, a magnetic resonance imaging is performed to search for any structural modifications.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* All consecutive patients who survived critical illness

Exclusion Criteria:

* Glasgow Coma Scale \< 15/15
* Confusion (CAM ICU scale)
* Refusal
```

## Interventions

- **Greyson NDE scale** (DIAGNOSTIC_TEST) — Questionnaire to detect occurence of NDE. A NDE is identified if score \> or = 7/32
- **DES dissociation scale** (DIAGNOSTIC_TEST) — Screening for dissociative symptoms
- **WHOQOL-SRPB** (DIAGNOSTIC_TEST) — WHOQOL-SRPB is an instrument developed to evaluate how spirituality, religiosity and personal beliefs (SRPB) are related to quality of life in health and health care.
- **cerebral magnetic resonance imaging** (DIAGNOSTIC_TEST) — Types of images to be acquired: T1, T2, Diffusion Weighted Imaging-DWI, Fluid Attenuated Inversion Recovery and spectroscopy

## Primary Outcomes

- **NDE** _(time frame: Greyson questionnaire is administered during the week following ICU discharge)_ — NDE occurence during ICU stay, retrospectively detected by the Greyson scale. Greyson scale is a 16 items and 32 points scale. Minimal score is 0, maximal score is 32. A NDE is suspected when score is equal or higher than 7.

## Secondary Outcomes

- **Quality of life estimation** _(time frame: one year after first interview)_
- **NDE** _(time frame: one year after first interview)_
- **MCQ (Memory Characteristics Questionnaire)** _(time frame: one month after first interview)_

## Locations (1)

- University Hospital of Liège, Liège, Belgium

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university hospital of liège|liège||belgium` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04279171.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04279171*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*